EP2154969
Meðferð við synucleinopathy-taugahrörnunarsjúkdómum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.5.2008EP published:
18.11.2015EP application number:
08755799.7
EP translation filed:
18.1.2016Grant published:
15.2.2016EPO information:
European Patent Register
Max expiry date:
15.5.2028Expiry date:
15.5.2020
Title:
TREATMENT OF SYNUCLEINOPATHIES
Timeline
Today
16.5.2008EP application
18.11.2015EP Publication
18.1.2016Translation submitted
15.2.2016Registration published
15.5.2020Expires
Owner
Name:
The Brigham and Women's Hospital, Inc.Address:
75 Francis Street, 02115, Boston, MA, US
Inventor
Name:
SCHLOSSMACHER, MichaelAddress:
OttawaOntarioK1J 9M9, CA
Name:
CULLEN, ValerieAddress:
Quincy, Massachusetts, US
Name:
SHIHABUDDIN, LamyaAddress:
Brighton, Massachusetts, US
Name:
CHENG, Seng, H.Address:
Natick, Massachusetts, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
930462 PDate:
16.5.2007Country:
US
Number:
929554 PDate:
3.7.2007Country:
US
Classification
Categories:
A01N 43/62, A61K 48/00, A61K 38/47, A61K 38/48
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 3.5.2016
Expires: 15.5.2017
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 2.5.2017
Expires: 15.5.2018
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 2.5.2018
Expires: 15.5.2019
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 2.5.2019
Expires: 15.5.2020
Payer: Sigurjónsson & Thor ehf.